Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.85
Bid: 7.50
Ask: 8.20
Change: 0.10 (1.29%)
Spread: 0.70 (9.333%)
Open: 7.75
High: 7.90
Low: 7.58
Prev. Close: 7.75
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Feb 2014 07:00

RNS Number : 2823A
Kromek Group PLC
18 February 2014
 



 

Kromek Group plc

("Kromek" or "the Company")

Directorate Change

 

Kromek, a supplier of patented radiation detection technologies to the medical, security and nuclear markets, announces that Ms. Maria Charlotta Ginman-Jones (known as Ms. Charlotta Ginman) has been appointed to the Company's Board as a Non-Executive Director with immediate effect.

 

Ms. Ginman, aged 48, will chair the Company's Audit Committee and brings with her substantial experience in financial and operational management gained during her successful executive career in the global telecommunications and investment banking sectors.

 

Currently a Non-Executive Director of Wolfson Microelectronics, and a member of Wolfson's Audit Committee, Ms. Ginman began her career at Ernst & Young LLP joining in 1989 until 1994, and was then appointed to a series of senior roles in investment banking with JP Morgan, Deutsche Bank and UBS.

 

During a career with Nokia Corporation, Ms. Ginman held many different roles, beginning as a business controller in the company's imaging division and progressing to the role of director of finance and control of the company's service business. Ms. Ginman has overseen a number acquisitions during her tenure at Nokia and became Chief Financial Officer of Nokia's luxury mobile phone division, Vertu Corporation Ltd, in 2009. Ms Ginman led the carve out of Vertu Corporation Ltd from Nokia and successfully sold the business to a private equity group.

 

A chartered accountant, Ms. Ginman also holds an MSc in Economics from the Swedish School of Economics and Business Administration in Helsinki.

 

Commenting on the announcement, Arnab Basu, CEO of Kromek, commented: "We are very pleased to welcome Charlotta to our Board. We will benefit greatly from her knowledge and experience that she has gained during an impressive career and her appointment further strengthens our Board."

 

"Charlotta joins Kromek at a very exciting time. Since joining AIM, we have accelerated our development and we are building on the success achieved in recent years, as we work to realise the value of our world-class technology platform."

 

Previous Directorships

Wolfson Microelectronics plc, Non-executive Director

Current Directorships

Ms. Ginman is not currently a director of any other company.

 

There is no other information that is required to be disclosed under Schedule 2 paragraph (g) of the AIM Rules in relation to the appointments of Ms. Ginman.

 

-ends-

 

For further information, please contact:

Kromek Group Plc

Arnab Basu, CEO

Derek Bulmer, CFO

 

Tel: 01740 626060

Panmure Gordon

As Nominated Adviser and Broker

Corporate Finance

Freddy Crossley/ Grishma Patel

Broking

Adam Pollock/ Charlie Leigh-Pemberton

 

Tel: 020 7886 2500

Tavistock Communications

Matt Ridsdale

Andrew Dunn

Tel: 020 7920 3150

 

About Kromek

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT"). Using its core CZT technology Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

Kromek uses multiple technologies in its manufacturing processes, including the established methods of 'liquid phase' detector production, and also 'vapour phase' production methods, which allow the production of high quality, high performance detectors on an industrial scale. Kromek has an intellectual property portfolio of more than 70 granted patents and 110 pending applications.

The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Board believes that the vertical integration offered by Kromek, combined with the benefit of 25 years of research into CZT production and the patents and trade secrets accumulated by the Group, are unparalleled in the market place.

The Group has operations in the UK, Germany and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over a hundred full time employees across its global operations.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFLTFEIDLIS
Date   Source Headline
3rd Aug 20222:00 pmRNSPrice Monitoring Extension
2nd Aug 20227:00 amRNSFinal Results
2nd Aug 20227:00 amRNSKromek wins over $750k in new orders
7th Jul 20227:00 amRNSKromek enters agreement with Smiths Detection Inc.
25th May 20227:00 amRNSNew Nuclear Security order from US federal entity
16th May 202212:07 pmRNSDirector Share Purchase
16th May 20227:00 amRNSBusiness and Trading Update
16th May 20227:00 amRNSAppointment of Nominated Adviser and Broker
4th Apr 20227:00 amRNSNew £1.7m CBRN contract
18th Jan 20227:00 amRNSInterim Results
17th Dec 20214:41 pmRNSSecond Price Monitoring Extn
17th Dec 20214:35 pmRNSPrice Monitoring Extension
14th Dec 20217:00 amRNSNotice of Results
26th Oct 20217:00 amRNSKromek awarded contract by US based OEM customer
29th Sep 20213:14 pmRNSHolding(s) in Company
27th Sep 20211:47 pmRNSDirector Share Purchase
23rd Sep 20217:00 amRNSNuclear security contract from US federal entity
8th Sep 202111:09 amRNSResult of AGM
13th Aug 20213:48 pmRNSNotice of AGM and Publication of Annual Report
3rd Aug 202112:25 pmRNSHolding(s) in Company
15th Jul 202111:05 amRNSSecond Price Monitoring Extn
15th Jul 202111:00 amRNSPrice Monitoring Extension
14th Jul 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSNew Contracts
1st Jul 20217:00 amRNSNotice of Results
24th Jun 20214:41 pmRNSSecond Price Monitoring Extn
24th Jun 20214:36 pmRNSPrice Monitoring Extension
14th Jun 20217:00 amRNSKromek awarded new DARPA bio-threat contract
12th May 20212:50 pmRNSDirector Share Purchase
11th May 20217:00 amRNSBusiness and Trading Update
21st Apr 20214:32 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSKromek awarded Nuclear Detection contract
4th Mar 20211:32 pmRNSHolding(s) in Company
2nd Mar 20218:30 amRNSPDMR Dealings
1st Mar 20212:53 pmRNSResults of Placing, Open Offer and General Meeting
1st Mar 20217:00 amRNSNew Medical Screening and Nuclear Security orders
19th Feb 20212:05 pmRNSSecond Price Monitoring Extn
19th Feb 20212:01 pmRNSPrice Monitoring Extension
15th Feb 20217:00 amRNSPosting of Circular
12th Feb 202111:05 amRNSSecond Price Monitoring Extn
12th Feb 202111:00 amRNSPrice Monitoring Extension
12th Feb 202110:30 amRNSPlacing and Open Offer to raise up to £13 million
4th Feb 20212:00 pmRNSIssue of Equity and Total Voting Rights
26th Jan 20215:15 pmRNSHolding(s) in Company
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20212:05 pmRNSSecond Price Monitoring Extn
22nd Jan 20212:00 pmRNSPrice Monitoring Extension
14th Jan 20214:41 pmRNSSecond Price Monitoring Extn
14th Jan 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.